Recently, the FDA announced the removal of certain compounded GLP1 ingredients from its drug shortage list. These ingredients ...

NVO's first-quarter revenues are expected to have been driven by its sales of diabetes and obesity care products, especially ...

Novo Nordisk is partnering with online telehealth companies to sell a direct-to-consumer, lower cost version of its popular weight-loss drug Wegovy. The pharmaceutical company announced it would ...

Pharma giant Novo Nordisk is partnering with telehealth companies to expand access to its blockbuster weight loss drug Wegovy. | Novo Nordisk and Hims & Hers have struck a truce after sparring over ...

Novo Nordisk has teamed up with Hims & Hers Health, LifeMD and Ro for cash-paying patients to access Wegovy injection 2.4 mg ...

Hims & Hers partners with Novo Nordisk to offer Wegovy access online with clinical support, expanding its weight loss care and revenue strategy.

Novo Nordisk (NVO) on Tuesday announced that it is enabling select telehealth providers to offer Wegovy, expanding access to ...

Semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, isn’t without its risks. A recent study has found ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Novo Nordisk partners with telehealth ...

Currently Wegovy has a list price of around $1,350 for a 28-day supply. This means that the medication could cost more than ...

With GLP-1 shortage officially over, patients who relied on compounded copies have only bad options to choose from ...

A doctor has warned of the potential dangers of a 'game changing' diabetes drug which could rival the likes of Ozempic. The medication - and similar drugs - have been catapulted into the heart of pop ...